By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cardioxyl Pharmaceuticals 



Towson  Maryland    U.S.A.
Phone: Fax:


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 7/28/2014 8:05:34 AM
New Findings Published in Circulation: Heart Failure Show Potential Utility of Cardioxyl Pharmaceuticals's HNO Donors as Novel Treatments for Heart Failure 10/28/2013 10:58:44 AM
Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., as Chief Medical Officer 9/11/2013 6:47:04 AM
Cardioxyl Pharmaceuticals Raises $28 Million in Venture Funding 11/8/2012 9:07:45 AM
Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session 4/5/2011 6:53:14 AM
Cardioxyl Pharmaceuticals Presents Data on its Clinical Candidate, Cxl-1020, at the 60th Annual American College of Cardiology Scientific Session 4/4/2011 2:23:51 PM
Cardioxyl Pharmaceuticals Strengthens Executive Team by Appointing James Gilbert, M.D., as Chief Medical Officer 1/11/2011 6:42:29 AM
Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients 8/26/2010 8:47:15 AM
Cardioxyl Pharmaceuticals Announces Positive Results from First Clinical Study of its Lead Therapy, CXL-1020, in Heart Failure Patients; Cardioxyl Also Secures an Additional $15 Million in Funding 8/2/2010 7:05:37 AM
Cardioxyl Pharmaceuticals' Data Presented at American College of Cardiology Annual Scientific Sessions 4/1/2010 9:49:34 AM
12
//-->